Oral semaglutide (25 mg) is effective for weight loss in adults with overweight or obesity without diabetes, according to a study.

HealthDay News — During August 2021 to August 2023, only 36.4 percent of U.S. adults had no cardiovascular disease (CVD) risk factors, according to a September data brief published by the National ...

In a clinical practice guideline published in Practical Radiation Oncology, recommendations are presented for the use of postmastectomy radiation therapy (PMRT).

Multicomponent physical activity interventions were generally associated with positive outcomes among pediatric patients with obesity.

Guidance is presented for understanding the impact of potassium and phosphorus additives on people with chronic kidney disease (CKD) and managing their consumption.

Pituitary adenoma risk factors included prior hyperparathyroidism, female sex, and non-missense pathogenic variants among patients with MEN1.

Insulin resistance was associated with adverse clinical outcomes among patients with PCOS and normal weight undergoing ...

Hormone replacement therapy (HRT) patches carry lower cardiovascular risk than oral HRT among women with type 2 diabetes.

The prevalence of T2D among a cohort of patients in Italy with SSc was lower than national estimates and associated with ...

President Donald Trump on Monday linked autism to acetaminophen use in pregnancy and vaccines — claims that scientists say are not supported by evidence.

GLP-1 RAs are not linked to an increased risk for serious GI or hepatobiliary outcomes, compared with other diabetes medications.

Early on-treatment liver stiffness measurements predict reduced risk for liver-related events in patients with CHB receiving antiviral therapy.